Description of immunogens of Chlamydia pneumoniae recognized by serum of individuals with peripheral artery disease;Descripción de inmunógenos de Chlamydia pneumoniae reconocidos por el suero de sujetos con enfermedad arterial periférica

Medicina Clinica

Volumn 126, Issue 19, 2006, Pages 721-727

  Gutiérrez, José ^a,d   Linares, José ^a,b   Camacho, Ana ^a   Palanca, Matilde ^a   Maroto, Carmen ^a   Ros, Eduardo ^a,b   De Dios Luna, Juan ^c   Soto, María José ^a   Sorlózano, Antonio ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^c VIRCELL S L   (Spain)

^d UNIVERSITY OF GRANADA   (Spain)

Author keywords

Antibody; Chlamydophila pneumoniae; DNA; Peripheral arterial disease

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; ARTERY DISEASE; ARTICLE; BIOPSY; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; SERUM; VASCULAR TISSUE; WESTERN BLOTTING;

EID: 33745656398     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13088945     Document Type: Article

References (71)

1. Danesh J, Whincup P, Lewington S, Walker M, Lenon L, Thomson A, et al. Chlamydia pneumoniae IgA titres and coronary heart disease: prospective study and meta-analysis. Eur Heart J. 2002;23:371-5.
2. Danesh J, Whincup P, Walker M, Lenon L, Thomson A, Appleby P, et al. Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. BMJ. 2000;321:208-13.
3. Danesh J, Whincup P, Walker M, Lenon L, Thomson A, Appleby P, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta analyses. BMJ. 2000; 321:199-204.
4. Gutiérrez J, Luna JD, Linares J, Montes MR, Quesada E, Soto MJ, et al. Relationship between peripheral arterial occlusive disease (PAOD) and chronic Chlamydophila (Chlamydia) pneumoniae infection: a meta-analysis. Throm Haemost. 2005;93:1153-60.
5. Fowkes FG, Housley E, Riemersma RA, Macintyre CC, Cawood EH, Prescott RJ. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol. 1992;135:331-40.
6. Alakärppä H, Surcel H-M, Laitinen K, Juvonen T, Saikku P, Laurilia A. Detection of Chlamydia pneumonias by colorimetric in situ hybridization. APMIS. 1999;107:451-4.
7. Al-Amro AA, Al-Jafari AA, Al-Fagih MR, Tajeldin M, Qavi HB. Frequency of occurrence of cytomegalovirus and Chlamydia pneumoniae in lymphocytes of atherosclerotic patients. Cent Eur J Public Health. 2001;9:106-8.
8. Berger M, Schroder B, Daeschlein G, Schneider W, Busjahn A, Buchwalow I, et al. Chlamydia pneumoniae DNA in non-coronary atherosclerotic plaques and circulating leukocytes. J Lab Clin Med. 2000;136:194-200.
9. Chiu B, Viira E, Tucker W, Fong IW. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation. 1997;96:2144-8.
10. Cook PJ, Honeybourne D, Lip GY, Beevers DG, Wise R, Davies P. Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project. Stroke. 1998;29:404-10.
11. Elkind MS, Lin IF, Grayston JT, Sacco RL. Chlamydia pneumoniae and the risk of first ischemic stroke: The Northern Manhattan Stroke Study. Stroke. 2000;31:1521-5.
12. Farsak B, Yildirir A, Akyon Y, Pinar A, Oc M, Boke E, et al. Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR. J Clin Microbiol. 2000;38:4408-11.
13. Freidank HM, Lux A, Dern P, Meyer-Konig U, Els T. Chlamydia pneumoniae DNA in peripheral venous blood samples from patients with carotid artery stenosis. Eur J Clin Microbiol Infect Dis. 2002;21:60-2.
14. Gil-Madre J, Garcia JL, Gonzalez RC, Montero JM, Paniagua EB, Escribano JR, et al. Association between seropositivity to Chlamydia pneumoniae and acute ischaemic stroke. Eur J Neurol. 2002;9:303-6.
15. Glader C, Stegmayr B, Boman J, Stenlund H, Weinehall L, Hallmans G, et al. Chlamydia pneumoniae antibodies and high lipoprotein(a) levels do not predict ischemic cerebral infarctions. Results from case-control study in Northern Sweden. Stroke. 1999;30:2013-8.
16. Goo Y, Moon H, Myung J, Kee B, Soo D, Jung A, et al. Serologic and histopathologic study of Chlamydia pneumoniae infection in atherosclerosis induced by Chlamydia pneumoniae. Yonsei Med J. 2000;41:319-27.
17. Gutiérrez J, Linares-Palomino J, López-Espada C, Rodriguez M, Ros E, Piedrola G, et al. Chlamydia pneumoniae DNA in the arterial wall of patients with peripheral vascular disease. Infection. 2001;29:196-200.
18. Gutiérrez-Fernández J, Linares-Palomino J, Fernández-Sánchez F, Guerrero-Fernández M, López Espada C, Ros-Díez E, et al. The presence of anti-Chlamydia pneumoniae antibodies in peripheral vascular and neurological disorders. Rev Neurol. 2001;32:501-5.
19. Juvonen J, Juvonen T, Laurila A, Alakärppä H, Lounatmaa K, Surcel HM, et al. Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms. J Vasc Surg. 1997;25:499-505.
20. Kalayoglu MV, Galvan C, Mahdi OS, Byrne GI, Mansour S. Serological association between Chlamydia pneumoniae infection and age-related macular degeneration. Arch Ophthalmol. 2003; 121:478-82.
21. Kol A, Sukhova GK, Lichtman AH, Libby P. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation. 1998;98:300-7.
22. Kuo CC, Gown AM, Benditt EP, Grayston JT. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb. 1993;13:1501-4.
23. LaBiche R, Koziol D, Quinn TC, Gaydos C, Azhar S, Ketron G, et al. Presence of Chlamydia pneumoniae in human symptomatic and asymptomatic carotid atherosclerotic plaque. Stroke. 2001; 32:855-60.
24. Lehto S, Niskanen L, Suhonen M, Ronnemaa T, Saikku P, Laakso M. Association between Chlamydia pneumoniae antibodies and intimal calcification in femoral arteries of nondiabetic patients. Arch Intern Med. 2002;162:594-9.
25. Lin TM, Chen WJ, Chen HY, Wang PW, Eng HL. Increased incidence of cytomegalovirus but not Chlamydia pneumoniae in atherosclerotic lesions of arteries of lower extremities from patients with diabetes mellitus undergoing amputation. J Clin Pathol. 2003;56:429-32.
26. Linares-Palomino J, Gutiérrez J, López-Espada C, Ros E, Moreno J, Pérez T, et al. Chlamydia pneumoniae and cerebrovascular disease. Rev Neural. 2001;32:201-6.
27. Maass M, Bartels C, Kruger S, Krause E, Engel PM, Dalhoff K. Endovascular presence of Chlamydia pneumoniae DNA is a generalized phenomenon in atherosclerotic vascular disease. Atherosclerosis. 1998;140 Suppl 1:25-30.
28. Maeda N, Sawayama Y, Tatsukawa M, Okada K, Furusyo N, Shigematsu M, et al. Carotid artery lesions and atherosclerotic risk factors in Japanese hemodialysis patients. Atherosclerosis. 2003;169:183-92.
29. Melnick SL, Shahar E, Folsom AR, Grayston JT, Sorlie PD, Wang SP, et al. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Am J Med. 1993;95:499-504.
30. Müller J, Möller DS, Kjaer M, Nyvad O, Larsen NA, Pedersen EB. Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in healthy control subjects and patients with diabetes mellitus, acute coronary syndrome, stroke, and arterial hypertension. Scand J Infect Dis. 2003;35:704-12.
31. Neureiter D, Heuschmann P, Stintzing S, Kolominsky-Rabas P, Barbera L, Jung A, et al. Detection of Chlamydia pneumoniae but not of Helicobacter pylori in symptomatic atherosclerotic carotids associated with enhanced serum antibodies, inflammation and apoptosis rate. Atherosclerosis. 2003;168:153-62.
32. Ong G, Thomas BJ, Mansfield AO, Davidson BR, Taylor-Robinson D. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol. 1996;49:102-6.
33. Ong GM, Coyle PV, Barros D'Sa AA, McCluggage WG, Duprex WP, O'Neill HJ, et al. Non-detection of Chlamydia species in carotid atheroma using generic primers by nested PCR in a population with a high prevalence of Chlamydia pneumoniae antibody. BMC Infect Dis. 2001;1:12.
34. Ouchi K, Fujii B, Kudo S, Shirai M, Yamashita K, Gondo T, et al. Chlamydia pneumonias in atherosclerotic and nonatherosclerotic tissue. J Infect Dis. 2000;181 Suppl 3:441-3.
35. Ramos PM, Ortega F, Samaniego J, Díaz R. Microscopia electrónica, Chlamydia pneumoniae y arteriosclerosis. Med Clin (Barc). 1999;112:277-8.
36. Rassu M, Cazzavillan S, Scagnelli M, Peron A, Bevilacqua PA, Facco M, et al. Demonstration of Chlamydia pneumoniae in atherosclerotic arteries from various vascular regions. Atherosclerosis. 2001;158:73-9.
37. Rose AG. Failure to detect Chlamydia pneumoniae in senile calcific aortic stenosis or calcified congenital bicuspid aortic valve by immunofluorescence, polymerase chain reaction and electron microscopy. Cardiovasc Pathol. 2002;11:300-4.
38. Sessa R, Di Pietro M, Schiavoni G, Santino I, Benedetti-Valentini F, Perna R, et al. Chlamydia pneumoniae DNA in patients with symptomatic carotid atherosclerotic disease. J Vasc Surg. 2003;37:1027-31.
39. Shi Y, Tokunaga O. Chlamydia pneumoniae and multiple infections in the aorta contribute to atherosclerosis. Pathol Int. 2002;52:755-63.
40. Tanne D, Haim M, Boyko V, Goldbourt U, Reshef T, Adler Y, et al. Prospective study of Chlamydia pneumoniae IgG and IgA seropositivity and risk of incident ischemic stroke. Cerebrovasc Dis. 2003;16:166-70.
41. Tarnacka B, Gromadzka G, Czlonkwska A. Increased circulating immune complexes in acute stroke. The triggering role of Chlamydia pneumoniae and cytomegalovirus. Stroke. 2002;33:936-40.
42. Taylor-Robinson D, Thomas BJ, Goldin R, Stanbridge R. Chlamydia pneumoniae in infrequently examined blood vessels. J Clin Pathol. 2002;55:218-20.
43. Van der Ven AJ, Hommels MJ, Kroon AA, Kessels A, Flobbe K, Van Engelshoven J, et al. Chlamydia pneumoniae seropositivity and systemic and renovascular atherosclerotic disease. Arch Intern Med. 2002;162:786-90.
44. Vécsei PV, Kircher K, Reitner A, Khanakah G, Stanek G. Chlamydia pneumoniae in central retinal artery occlusion. Acta Ophthalmol Scand. 2002;80:656-9.
45. Vécsei PV, Kircher K, Reitner A, Khanakha G, Stanek G. Chlamydia in anterior ischemic optic neuropathy. Ophthalmologica. 2002;216:215-20.
46. Virok D, Kis Z, Karai L, Intzedy L, Burian K, Szabo A, et al. Chlamydia pneumoniae in atherosclerotic middle cerebral artery. Stroke. 2001;32:1973-6.
47. Wimmer ML, Sandmann-Strupp R, Saikku P, Haberl RL. Association of chlamydial infection with cerebrovascular disease. Stroke. 1996;27:2207-10.
48. Wolf SC, Mayer O, Jurgens S, Vonthein R, Schultze G, Risler T, et al. Chlamydia pneumoniae IgA seropositivity is associated with increased risk for atherosclerotic vascular disease, myocardial infarction and stroke in dialysis patients. Clin Nephrol. 2003;59:273-9.
49. Gutiérrez J, Linares J, Fernández F, Ros E, Luna JD, Mendoza J, et al. Relación entre la enfermedad arterial periférica oclusiva y la infección por Chlamydophila pneumoniae. Med Clin (Barc). 2004;3:561-6.
50. Roblin PM, Dumornay W, Hammerschlag MR. Use of Hep-2 cells for improved isolation and passage of Chlamydia pneumoniae. J Clin Microbiol. 1992;30:1968-71.
51. Ladany S, Black CM, Farshy CE, Ossewaarde JM, Barnes RC. Enzyme immunoassay to determine exposure to Chlamydia pneumoniae (strain TWAR). J Clin Microbiol. 1989;27:2778-83.
52. Essig A, Simnacher U, Milorad S, Marre R. Analysis of the humoral immune response to Chlamydia pneumoniae by immunoblotting and immunoprecipitation. Clin Diagnost Lab Immunol. 1999;6:819-25.
53. Stephens RS, Lammel CJ. Chlamydia outer membrane protein discovery using genomics. Curr Opin Microbiol. 2001;4:16-20.
54. Biendo M, Eb F, Lefebvre F, Orfila J. Limits of the immunofluorescence test and advantages of immunoblotting in the diagnosis of chlamydiosis. Clin Diagn Lab Immunol. 1996;3:706-9.
55. th International Symposium on Human Chlamydial Infections; 1998; Napa. p. 279-82.
56. Kido Y, Shirai M, Ouchi K, Nakazawa T. Analysis of the serological response to Chlamydia pneumoniae in patients with ischemic heart disease by recombinant MOMP-ELISA. J Infect Chemother. 2001;7:180-5.
57. Maass M, Gieffers J. Cardiovascular disease risk from prior Chlamydia pneumoniae infection can be related to certain antigens recognized in the immunoblot profile. J Infect. 1997;35:171-6.
58. Montigiani S, Falugi F, Scarselli M, Finco O, Petracca R, Galli G, et al. Genomic approach for analysis of surface proteins in Chlamydia pneumoniae. Infect Immun. 2002;70:368-79.
59. Vandahl BB, Birkelund S, Demol H, Hoorelbeke B, Christiansen G, Vandekerckhove J, et al. Proteome analysis of the Chlamydia pneumoniae elementary body. Electrophoresis. 2001;22:1204-23.
60. Campbell LA, Roberts S, Inoue S, Kong L, Kuo CC. Evaluation of Chlamydia pneumoniae 43- and 53-kilodalton recombinant proteins for serodiagnosis by western blot. Clin Diag Lab Immunol. 2001;8:1231-3.
61. Wiedmann-Al-Ahmad M, Schuessler P, Freidank H. Reactions of polyclonal and neutralizing anti-p54 monoclonal antibodies with an isolated, species-specific 54 kilodaltonprotein of Chlamydia pneumoniae. Clin Diag Lab Immunol. 1997; 4:700-4.
62. Mygind P, Christiansen G, Persson K, Birkelund S. Analysis of the humoral immune response to Chlamydia outer membrane protein 2. Clin Diag Lab Immunol. 1998;5:313-8.
63. Campbell LA, Kuo CC. Chlamydia pneumoniae - an infectious risk factor for atherosclerosis? Nat Rev Microbiol. 2004;2:23-32.
64. Belunis CJ, Mdluli KE, Raetz CR. A novel 3-deoxy-D-manno-octulosonic acid transferase from Chlamydia trachomatis required for expression of the genus-specific epitope. J Biol Chem. 1992;267:18702-7.
65. Eng HL, Chen CH, Kuo CH, Wu JS, Wang CH, Lin TM. Association of CD14 promoter gene polymorphism and Chlamydia pneumoniae infection. J Infect Dis. 2003;188:90-7.
66. Hermann C, Graf K, Groh A, Straube E, Hartung T. Comparison of eleven commercial tests for Chlamydia pneumoniae-specific immunoglobulin G in asymptomatic healthy individuals. J Clin Microbiol. 2002;40:1603-9.
67. Ossewaarde JM. Introducing Chlamydophila pneumoniae: the TWAR agent Chlamydia pneumoniae in a new perspective. Neth J Med. 2001; 59:41-4.
68. Saikku P. Chlamydia pneumoniae in atherosclerosis. J Intern Med. 2000;247:391-6.
69. Stephens RS. The cellular paradigm of Chlamydial pathogenesis. Trends Microbiol. 2003;11:44-51.
70. Kalayoglu MV, Indrawati V, Morrison RP, Morrison SG, Yuan Y, Byrne GI. Chlamydial virulence determinants in atherogenesis: the role of chlamydial lipopolysaccharide and heat shock protein 60 in macrophage-lipoprotein interactions. J Infect Dis. 2000;181:483-9.
71. Vehmaan-Kreula P, Puolakkainen M, Sarvas M, Welgus HG, Kovanen PT. Chlamydia pneumoniae proteins induce secretion of the 92- kDa gelatinase by human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol. 2001;21:1-8.